Drugs / ATG-F
last change Sep 2010 re-read 3 minutes ago

ATG-F

Developed for
graft versus host disease
Investigated by
Hadassah Medical Organization

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00616954 May 2008 → Jun 2010 graft versus host disease Hadassah Medical Organization Terminated No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ATG-F ClinicalTrials.gov intervention name — accepted as the source's own label NCT00616954 ↗